JAZZ
Jazz Pharmaceuticals Stock Analysis
AI Rating
- Quality4/10
- Growth↓ 1/10
- Value↓ 1/10
JAZZ Growth
- Revenue Y/Y↓ 4.88%
- EPS Y/Y↓ -164.46%
- FCF Y/Y↓ -2.40%
JAZZ Profitability
- Gross margin ↑ 88.20%
- EPS margin↓ -8.30%
- ROIC 5Y↓ 2.85%
JAZZ Risk
- Debt / Equity↓ 1.3
- Debt / FCF↓ 3.0
- Interest coverage↓ -2.2
Jazz Pharmaceuticals stock is less volatile than the overall market, so it's low risk. We give it a Good risk rating.